ADBE

Adobe Inc.

80
Fundamentals69/ 100
Valuation93/ 100
Upside potential79/ 100
Risk potential13/ 100

ADBE has the edge over CRWD overall, supported by stronger valuation and stronger modeled upside.

CRWD

CrowdStrike Holdings, Inc.

63
Fundamentals83/ 100
Valuation32/ 100
Upside potential65/ 100
Risk potential26/ 100

CRWD offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.

ADBE Fundamentals

MetricStatus
Healthy
Strong
Strong
Strong

ADBE's revenue, profitability, cash flow and balance sheet are all currently healthy.

CRWD Fundamentals

MetricStatus
Healthy
Stable
Strong
Unavailable

CRWD's revenue and cash flow are currently healthy, and its profitability is stable. There isn't enough data to rate its balance sheet.

ADBE PE Valuation

CHEAPFAIREXPENSIVE18x35x53x71x
CHEAPFAIREXPENSIVE18x35x53x71x
LevelPEPriceVs current
Forward8.9x$239—
Current13x$239—
Cheap22x$396+66%
Fair43x$771+223%
Expensive54x$972+308%

Historical ranges are pointers, not guarantees.

ADBE has the edge over CRWD in the historical PE scenario, which offers more potential upside but is not a forecast.

CRWD PE Valuation

CHEAPFAIREXPENSIVE1144x2288x3432x4577x
CHEAPFAIREXPENSIVE1144x2288x3432x4577x
LevelPEPriceVs current
Forward153x$230—
Cheap451x$27.04-88%
Fair715x$42.92-81%
Expensive3,337x$200-13%
Current3,678x$230—

Historical ranges are pointers, not guarantees.

CRWD's PE is in its expensive range at 3678x. If earnings grow as analysts expect, today's price would be 153x next year's earnings, in its cheap range.

ADBE Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Improving
Moderate
Moderate

Analysts expect earnings and revenue growth for ADBE, with profitability improving.

CRWD Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Improving
Broad
High

Analysts expect strong earnings and revenue growth for CRWD, with profitability improving.

ADBE Risk to reward

ScenarioChangePrice
Upside+48%$353.31
Downside-13%$208.15

Calculated from the latest close: $238.54 on Nov 12.

ADBE has a better modeled risk to reward balance than CRWD, with more potential upside relative to its potential downside.

CRWD Risk to reward

ScenarioChangePrice
Upside+48%$341.14
Downside-26%$170.12

Calculated from the latest close: $229.87 on Nov 12.

CRWD trails ADBE on modeled risk to reward, with less potential upside relative to its potential downside.

ADBE Earnings Per Share

Q4 2023: $11.82Q1 2024: $10.47Q2 2024: $11.14Q3 2024: $11.85Q4 2024: $12.36Q1 2025: $15.14Q2 2025: $15.59Q3 2025: $16.01Q4 2025: $16.70Q1 2026: $17.16Q2 2026: $17.47Q3 2026: $17.91Forward: $26.84
Q4 2023: $11.82Q1 2024: $10.47Q2 2024: $11.14Q3 2024: $11.85Q4 2024: $12.36Q1 2025: $15.14Q2 2025: $15.59Q3 2025: $16.01Q4 2025: $16.70Q1 2026: $17.16Q2 2026: $17.47Q3 2026: $17.91Forward: $26.84
QuarterTTM EPSYoY
Forward$26.84+50%
Q3 2026$17.91+12%
Q2 2026$17.47+12%
Q1 2026$17.16+13%
Q4 2025$16.70+35%
Q3 2025$16.01+35%
Q2 2025$15.59+40%
Q1 2025$15.14+45%
Q4 2024$12.36+4.6%

ADBE has the edge over CRWD on earnings, with more consistent year-over-year improvement.

CRWD Earnings Per Share

Q4 2023: $-0.02Q1 2024: $0.09Q2 2024: $0.14Q3 2024: $0.17Q4 2024: $0.13Q1 2025: $-0.02Q2 2025: $-0.17Q3 2025: $-0.30Q4 2025: $-0.32Q1 2026: $-0.16Q2 2026: $-0.03Q3 2026: $0.06Forward: $1.50
Q4 2023: $-0.02Q1 2024: $0.09Q2 2024: $0.14Q3 2024: $0.17Q4 2024: $0.13Q1 2025: $-0.02Q2 2025: $-0.17Q3 2025: $-0.30Q4 2025: $-0.32Q1 2026: $-0.16Q2 2026: $-0.03Q3 2026: $0.06Forward: $1.50
QuarterTTM EPSYoY
Forward$1.50+2400%
Q3 2026$0.06+$0.36
Q2 2026-$0.03+$0.14
Q1 2026-$0.16-$0.14
Q4 2025-$0.32-346%
Q3 2025-$0.30-276%
Q2 2025-$0.17-221%
Q1 2025-$0.02-122%
Q4 2024$0.13+$0.15

CRWD has returned to profit: it earned $0.06 per share over the past year, after losing money the year before.

ADBE Quarterly Revenue

Q4 2023: $5BQ1 2024: $5.2BQ2 2024: $5.3BQ3 2024: $5.4BQ4 2024: $5.6BQ1 2025: $5.7BQ2 2025: $5.9BQ3 2025: $6BQ4 2025: $6.2BQ1 2026: $6.4BQ2 2026: $6.6BQ3 2026: $6.8B
Q4 2023: $5BQ1 2024: $5.2BQ2 2024: $5.3BQ3 2024: $5.4BQ4 2024: $5.6BQ1 2025: $5.7BQ2 2025: $5.9BQ3 2025: $6BQ4 2025: $6.2BQ1 2026: $6.4BQ2 2026: $6.6BQ3 2026: $6.8B
QuarterRevenueYoY
Q3 2026$6.8B+13%
Q2 2026$6.6B+13%
Q1 2026$6.4B+12%
Q4 2025$6.2B+10%
Q3 2025$6B+11%
Q2 2025$5.9B+11%
Q1 2025$5.7B+10%
Q4 2024$5.6B+11%

ADBE's revenue has grown year over year every quarter since late 2020: $6.8B last quarter, up 13% from the same quarter a year ago.

CRWD Quarterly Revenue

Q4 2023: $786MQ1 2024: $845MQ2 2024: $921MQ3 2024: $964MQ4 2024: $1BQ1 2025: $1.1BQ2 2025: $1.1BQ3 2025: $1.2BQ4 2025: $1.2BQ1 2026: $1.3BQ2 2026: $1.4BQ3 2026: $1.5B
Q4 2023: $786MQ1 2024: $845MQ2 2024: $921MQ3 2024: $964MQ4 2024: $1BQ1 2025: $1.1BQ2 2025: $1.1BQ3 2025: $1.2BQ4 2025: $1.2BQ1 2026: $1.3BQ2 2026: $1.4BQ3 2026: $1.5B
QuarterRevenueYoY
Q3 2026$1.5B+26%
Q2 2026$1.4B+26%
Q1 2026$1.3B+23%
Q4 2025$1.2B+22%
Q3 2025$1.2B+21%
Q2 2025$1.1B+20%
Q1 2025$1.1B+25%
Q4 2024$1B+29%

CRWD has the edge over ADBE on sales, with stronger typical year-over-year growth.

ADBE Free Cash Flow

Q4 2023: $1.6BQ1 2024: $1.1BQ2 2024: $1.9BQ3 2024: $2BQ4 2024: $2.9BQ1 2025: $2.5BQ2 2025: $2.1BQ3 2025: $2.1BQ4 2025: $3.1BQ1 2026: $2.9BQ2 2026: $2.1BQ3 2026: $2.4B
Q4 2023: $1.6BQ1 2024: $1.1BQ2 2024: $1.9BQ3 2024: $2BQ4 2024: $2.9BQ1 2025: $2.5BQ2 2025: $2.1BQ3 2025: $2.1BQ4 2025: $3.1BQ1 2026: $2.9BQ2 2026: $2.1BQ3 2026: $2.4B
QuarterFree cash flowYoY
Q3 2026$2.4B+15%
Q2 2026$2.1B-1.7%
Q1 2026$2.9B+19%
Q4 2025$3.1B+8.8%
Q3 2025$2.1B+8.2%
Q2 2025$2.1B+13%
Q1 2025$2.5B+116%
Q4 2024$2.9B+85%

ADBE's free cash flow has been positive every quarter for seven years: $10.6B over the past year, up 10% from the year before.

CRWD Free Cash Flow

Q4 2023: $252MQ1 2024: $294MQ2 2024: $334MQ3 2024: $287MQ4 2024: $247MQ1 2025: $259MQ2 2025: $298MQ3 2025: $302MQ4 2025: $314MQ1 2026: $395MQ2 2026: $493MQ3 2026: $406M
Q4 2023: $252MQ1 2024: $294MQ2 2024: $334MQ3 2024: $287MQ4 2024: $247MQ1 2025: $259MQ2 2025: $298MQ3 2025: $302MQ4 2025: $314MQ1 2026: $395MQ2 2026: $493MQ3 2026: $406M
QuarterFree cash flowYoY
Q3 2026$405.9M+34%
Q2 2026$493.3M+65%
Q1 2026$395.4M+53%
Q4 2025$314.1M+27%
Q3 2025$302.3M+5.2%
Q2 2025$298.4M-11%
Q1 2025$258.5M-12%
Q4 2024$247.4M-1.9%

CRWD's free cash flow has been positive every quarter for seven years: $1.6B over the past year, up 45% from the year before.

ADBE Total Shares

Q4 2023: 459MQ1 2024: 456MQ2 2024: 451MQ3 2024: 448MQ4 2024: 450MQ1 2025: 438MQ2 2025: 429MQ3 2025: 424MQ4 2025: 427MQ1 2026: 411MQ2 2026: 403MQ3 2026: 396M
Q4 2023: 459MQ1 2024: 456MQ2 2024: 451MQ3 2024: 448MQ4 2024: 450MQ1 2025: 438MQ2 2025: 429MQ3 2025: 424MQ4 2025: 427MQ1 2026: 411MQ2 2026: 403MQ3 2026: 396M
PeriodChange %Net change
Quarterly-1.7%-7M shares
1 year-6.7%-28.6M shares
3 years-14%-64M shares
5 years-18%-85.2M shares
Available history-20%-96.1M shares

ADBE has the edge over CRWD on shareholder dilution, with a more favorable share count trend.

CRWD Total Shares

Q4 2023: 975MQ1 2024: 975MQ2 2024: 1BQ3 2024: 1BQ4 2024: 982MQ1 2025: 979MQ2 2025: 994MQ3 2025: 1000MQ4 2025: 1BQ1 2026: 1BQ2 2026: 1BQ3 2026: 1B
Q4 2023: 975MQ1 2024: 975MQ2 2024: 1BQ3 2024: 1BQ4 2024: 982MQ1 2025: 979MQ2 2025: 994MQ3 2025: 1000MQ4 2025: 1BQ1 2026: 1BQ2 2026: 1BQ3 2026: 1B
PeriodChange %Net change
Quarterly+1.3%+12.9M shares
1 year+4.5%+44.8M shares
3 years+7.8%+75.9M shares
5 years+15%+139M shares
Available history+28%+228M shares

CRWD has 1B diluted shares, up 4.5% from a year ago.

ADBE Net Leverage

Q4 2023: -0.5xQ1 2024: -0.6xQ2 2024: -0.5xQ3 2024: -0.4xQ4 2024: -0.5xQ1 2025: -0.1xQ2 2025: 0.1xQ3 2025: 0.1xQ4 2025: 0.1xQ1 2026: -0.1xQ2 2026: -0.0xQ3 2026: 0.0x
Q4 2023: -0.5xQ1 2024: -0.6xQ2 2024: -0.5xQ3 2024: -0.4xQ4 2024: -0.5xQ1 2025: -0.1xQ2 2025: 0.1xQ3 2025: 0.1xQ4 2025: 0.1xQ1 2026: -0.1xQ2 2026: -0.0xQ3 2026: 0.0x
QuarterNet LeverageStatus
Q3 20260.0xVery low
Q2 2026-0.0xNet Cash
Q1 2026-0.1xNet Cash
Q4 20250.1xVery low
Q3 20250.1xVery low
Q2 20250.1xVery low
Q1 2025-0.1xNet Cash
Q4 2024-0.5xNet Cash

ADBE's net debt is less than a year of its operating earnings (EBITDA).

CRWD Net Leverage

ADBE Weekly Momentum

MetricValueStatus
RSI45.4Neutral
Stochastic25.8Neutral

ADBE's weekly RSI is 45 (neutral) and its Stochastic is 26 (neutral).

CRWD Weekly Momentum

MetricValueStatus
RSI55.1Neutral
Stochastic49.1Neutral

CRWD's weekly RSI is 55 (neutral) and its Stochastic is 49 (neutral).

ADBE PE vs Technology Sector

MetricADBESector medianRelative
PE13x28x52% below
PE %33532 pts below

ADBE has the edge over CRWD on valuation relative to its sector.

CRWD PE vs Technology Sector

MetricCRWDSector medianRelative
PE3,678x28x13,101% above
PE %913556 pts above

CRWD is trading at 3678x earnings, a 13101% premium to the Technology sector's median of 28x.

ADBE Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$244.12.3% below
20 week MA$248.64.1% below
50 week MA$261.68.8% below
100 week MA$321.826% below
200 week MA$410.642% below

ADBE is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.

CRWD Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$247.47.1% below
20 week MA$221.93.6% above
50 week MA$163.041% above
100 week MA$136.069% above
200 week MA$97.5136% above

CRWD has the edge over ADBE on trend strength, trading above more of its moving averages.

ADBE Yearly ROI

YearStart priceEnd priceROI
2020$330.8$499.9+51%
2021$499.9$569.6+14%
2022$569.6$338.5-41%
2023$338.5$596.6+76%
2024$596.6$446.5-25%
2025$446.5$353.8-21%
2026 YTD$353.8$238.5-33%

ADBE has finished lower in three of the last six years. It's down 33% so far in 2026.

CRWD Yearly ROI

YearStart priceEnd priceROI
2020$12.2$55.3+352%
2021$55.3$52.9-4.3%
2022$52.9$25.5-52%
2023$25.5$63.8+150%
2024$63.8$88.8+39%
2025$88.8$120.3+36%
2026 YTD$120.3$229.9+91%

CRWD has the edge over ADBE on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key